Simon Amy

Simon Amy is listed in filings as Chief Medical Officer at Beam Therapeutics Inc.. This profile follows SEC Form 4 activity through Jul 2, 2026, including sale activity. Recent filings connect the profile to Beam Therapeutics Inc. (BEAM). The current snapshot covers public activity from Jul 2, 2026. Reported amounts are shown as $13.0K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.